(Stroke. 2000;31:3079-a.)
© 2000 American Heart Association, Inc.
Letters to the Editor |
Senior Neurology Registrar, Sir Charles Gairdner Hospital, Verdun Street, Nedlands, Perth, Western Australia
Key Words: stroke,
acute thrombolysis ultrasonography,
Doppler, transcranial
To the Editor:
Alexandrov et al1 raise a fascinating possibility in their paper on transcranial Doppler monitoring of recanalization during systemic tPA infusion in acute ischemic stroke. They postulate that ultrasonic energy focused on intracranial thrombus might facilitate thrombolysis. It is easy to imagine how an even more precise beam of energy could be directed at intracranial thrombus with the goal of clot dissolution; why not combine MR angiography with stereotactically delivered magnetic or radiation energy? Could this be a stroke treatment of the future, using technology that exists now?
References
1.
Alexandrov AV, Demchuk AM, Felberg RA, Christou I,
Barber PA, Burgin WS, Malkoff M, Wojner AW, Grotta JC. High rate of
recanalization and dramatic clinical recovery
during tPA infusion when continuously monitored with 2-MHz
transcranial Doppler monitoring. Stroke.. 2000;31:610614.
Stroke Program, University of TexasHouston Medical School
I would like to thank Dr Blacker for his letter that highlights an intriguing possibility of using beams, waves, and fields of different physical nature to treat stroke. Indeed, the ideas of thrombolysis with ultrasound alone R1 or combined with a lytic drugR2 have been expressed long ago and since confirmed by many in several in vitro and animal experiments. Technological advances in other areas broadened applications of magnetic resonance into the interventional arena: image guided tracking of vascular guidewiresR3 and better focusing of an electron beam therapy in terms of dose distribution in biological tissues R4 . Improvements in computer technology and development of portable high resolution diagnostic and interventional equipment can one day make these "Star-Trek" visions of future therapies a reality in the emergency rooms and physician offices.
A necessary step, however, has to cover this gap in time: demonstration
of safety and efficacy. The first concern is that focusing on a clot
any beam or field (that is
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |